MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617055065 A) filed by Rheinische Friedrich-Wilhelms Universitt Bonn on April 30, 2026, for Composition Comprising Beta-2-Adrenergic Receptor Agonist For Transdermal Administration.
Inventors include Pfeifer, Alexander; Niu, Zheming; Kappes, Sebastian Kalju; and Lamprecht, Alf.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention relates to a composition for transdermal administration, the composition comprising a compound selected from the group comprising formoterol, salbutamol, salmeterol, fenoterol, a mixture thereof, or a salt thereof, and dimethyl sulfoxide. The invention further relates to a composition comprising a compound selected from the group comprising salbutamol, clenbuterol, or a salt thereof, and comprises at least one of a monoalcohol or water.
Disclaimer: Curated by HT Syndication.
